nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—SLC22A5—Organic cation transport—SLC22A18—breast cancer	0.00934	0.148	CbGpPWpGaD
Cefixime—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.00634	0.1	CbGpPWpGaD
Cefixime—SLC15A2—mammary gland—breast cancer	0.00432	0.0952	CbGeAlD
Cefixime—SLC15A1—epithelium—breast cancer	0.00384	0.0848	CbGeAlD
Cefixime—SLC22A5—mammary gland—breast cancer	0.00375	0.0828	CbGeAlD
Cefixime—SLC15A1—endometrium—breast cancer	0.00345	0.076	CbGeAlD
Cefixime—SLC22A5—nipple—breast cancer	0.0031	0.0685	CbGeAlD
Cefixime—SLC15A1—endocrine gland—breast cancer	0.00242	0.0533	CbGeAlD
Cefixime—SLC15A2—endometrium—breast cancer	0.00216	0.0475	CbGeAlD
Cefixime—SLC22A5—skin of body—breast cancer	0.00199	0.0439	CbGeAlD
Cefixime—SLC15A2—pituitary gland—breast cancer	0.00195	0.043	CbGeAlD
Cefixime—SLC22A5—endometrium—breast cancer	0.00187	0.0413	CbGeAlD
Cefixime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00187	0.0296	CbGpPWpGaD
Cefixime—SLC15A2—female reproductive system—breast cancer	0.00179	0.0394	CbGeAlD
Cefixime—SLC15A2—adrenal gland—breast cancer	0.00174	0.0384	CbGeAlD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00173	0.0274	CbGpPWpGaD
Cefixime—SLC22A5—pituitary gland—breast cancer	0.0017	0.0374	CbGeAlD
Cefixime—SLC22A5—adipose tissue—breast cancer	0.00169	0.0373	CbGeAlD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00167	0.0265	CbGpPWpGaD
Cefixime—SLC15A2—female gonad—breast cancer	0.00162	0.0358	CbGeAlD
Cefixime—SLC22A5—female reproductive system—breast cancer	0.00155	0.0343	CbGeAlD
Cefixime—SLC22A5—adrenal gland—breast cancer	0.00152	0.0334	CbGeAlD
Cefixime—SLC15A2—endocrine gland—breast cancer	0.00151	0.0333	CbGeAlD
Cefixime—SLC22A5—female gonad—breast cancer	0.00141	0.0312	CbGeAlD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00139	0.022	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00127	0.0201	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00122	0.0194	CbGpPWpGaD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00105	0.0167	CbGpPWpGaD
Cefixime—SLC15A2—lymph node—breast cancer	0.00104	0.023	CbGeAlD
Cefixime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.00096	0.0152	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000912	0.0145	CbGpPWpGaD
Cefixime—SLC22A5—lymph node—breast cancer	0.000908	0.02	CbGeAlD
Cefixime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000891	0.0141	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000846	0.0134	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000834	0.0132	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000834	0.0132	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000832	0.0132	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000774	0.0123	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000774	0.0123	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000761	0.0121	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000761	0.0121	CbGpPWpGaD
Cefixime—Diarrhoea—Melphalan—breast cancer	0.000718	0.000806	CcSEcCtD
Cefixime—Gastrointestinal pain—Thiotepa—breast cancer	0.000716	0.000803	CcSEcCtD
Cefixime—Haemoglobin—Capecitabine—breast cancer	0.000716	0.000803	CcSEcCtD
Cefixime—Nausea—Chlorambucil—breast cancer	0.000715	0.000802	CcSEcCtD
Cefixime—Haemorrhage—Capecitabine—breast cancer	0.000713	0.000799	CcSEcCtD
Cefixime—Hepatitis—Capecitabine—breast cancer	0.000713	0.000799	CcSEcCtD
Cefixime—Thrombocytopenia—Fluorouracil—breast cancer	0.000709	0.000796	CcSEcCtD
Cefixime—Dizziness—Tamoxifen—breast cancer	0.000709	0.000795	CcSEcCtD
Cefixime—Vomiting—Vinblastine—breast cancer	0.000702	0.000787	CcSEcCtD
Cefixime—Diarrhoea—Goserelin—breast cancer	0.000701	0.000786	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—breast cancer	0.000698	0.000783	CcSEcCtD
Cefixime—Erythema multiforme—Docetaxel—breast cancer	0.000696	0.000781	CcSEcCtD
Cefixime—Urticaria—Thiotepa—breast cancer	0.000696	0.000781	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—breast cancer	0.000695	0.000779	CcSEcCtD
Cefixime—Face oedema—Epirubicin—breast cancer	0.000693	0.000777	CcSEcCtD
Cefixime—Abdominal pain—Thiotepa—breast cancer	0.000693	0.000777	CcSEcCtD
Cefixime—Body temperature increased—Thiotepa—breast cancer	0.000693	0.000777	CcSEcCtD
Cefixime—Headache—Vinblastine—breast cancer	0.000691	0.000776	CcSEcCtD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000691	0.011	CbGpPWpGaD
Cefixime—Angioedema—Paclitaxel—breast cancer	0.000691	0.000775	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Methotrexate—breast cancer	0.000691	0.000775	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000686	0.00077	CcSEcCtD
Cefixime—Vomiting—Tamoxifen—breast cancer	0.000682	0.000765	CcSEcCtD
Cefixime—Dizziness—Goserelin—breast cancer	0.000677	0.00076	CcSEcCtD
Cefixime—Leukopenia—Paclitaxel—breast cancer	0.000677	0.000759	CcSEcCtD
Cefixime—Rash—Tamoxifen—breast cancer	0.000676	0.000758	CcSEcCtD
Cefixime—Hypersensitivity—Vinorelbine—breast cancer	0.000676	0.000758	CcSEcCtD
Cefixime—Dermatitis—Tamoxifen—breast cancer	0.000675	0.000758	CcSEcCtD
Cefixime—Erythema multiforme—Capecitabine—breast cancer	0.000674	0.000756	CcSEcCtD
Cefixime—Headache—Tamoxifen—breast cancer	0.000672	0.000753	CcSEcCtD
Cefixime—Vomiting—Melphalan—breast cancer	0.000668	0.000749	CcSEcCtD
Cefixime—Dyspepsia—Mitoxantrone—breast cancer	0.000666	0.000747	CcSEcCtD
Cefixime—Dyspepsia—Irinotecan—breast cancer	0.000666	0.000747	CcSEcCtD
Cefixime—Rash—Melphalan—breast cancer	0.000662	0.000743	CcSEcCtD
Cefixime—Dermatitis—Melphalan—breast cancer	0.000661	0.000742	CcSEcCtD
Cefixime—Eosinophilia—Methotrexate—breast cancer	0.000656	0.000736	CcSEcCtD
Cefixime—Nausea—Vinblastine—breast cancer	0.000656	0.000735	CcSEcCtD
Cefixime—Convulsion—Paclitaxel—breast cancer	0.000655	0.000735	CcSEcCtD
Cefixime—Vomiting—Goserelin—breast cancer	0.000651	0.00073	CcSEcCtD
Cefixime—Pruritus—Vinorelbine—breast cancer	0.000649	0.000728	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000646	0.000725	CcSEcCtD
Cefixime—Rash—Goserelin—breast cancer	0.000646	0.000724	CcSEcCtD
Cefixime—Hypersensitivity—Thiotepa—breast cancer	0.000645	0.000724	CcSEcCtD
Cefixime—Dermatitis—Goserelin—breast cancer	0.000645	0.000724	CcSEcCtD
Cefixime—Headache—Goserelin—breast cancer	0.000642	0.00072	CcSEcCtD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000641	0.0102	CbGpPWpGaD
Cefixime—Face oedema—Doxorubicin—breast cancer	0.000641	0.000719	CcSEcCtD
Cefixime—Dyspepsia—Fluorouracil—breast cancer	0.000638	0.000715	CcSEcCtD
Cefixime—Nausea—Tamoxifen—breast cancer	0.000637	0.000714	CcSEcCtD
Cefixime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000633	0.01	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000632	0.01	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000631	0.01	CbGpPWpGaD
Cefixime—Pancytopenia—Methotrexate—breast cancer	0.000629	0.000706	CcSEcCtD
Cefixime—Diarrhoea—Vinorelbine—breast cancer	0.000628	0.000704	CcSEcCtD
Cefixime—Nausea—Melphalan—breast cancer	0.000624	0.0007	CcSEcCtD
Cefixime—Neutropenia—Methotrexate—breast cancer	0.00062	0.000695	CcSEcCtD
Cefixime—Pruritus—Thiotepa—breast cancer	0.00062	0.000695	CcSEcCtD
Cefixime—Gastrointestinal pain—Irinotecan—breast cancer	0.000619	0.000694	CcSEcCtD
Cefixime—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000619	0.000694	CcSEcCtD
Cefixime—Anaphylactic shock—Paclitaxel—breast cancer	0.000617	0.000692	CcSEcCtD
Cefixime—Eosinophilia—Epirubicin—breast cancer	0.000614	0.000689	CcSEcCtD
Cefixime—Flatulence—Capecitabine—breast cancer	0.000611	0.000686	CcSEcCtD
Cefixime—Nausea—Goserelin—breast cancer	0.000608	0.000682	CcSEcCtD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000608	0.00964	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000608	0.00964	CbGpPWpGaD
Cefixime—Shock—Paclitaxel—breast cancer	0.000607	0.000681	CcSEcCtD
Cefixime—Dizziness—Vinorelbine—breast cancer	0.000607	0.00068	CcSEcCtD
Cefixime—Thrombocytopenia—Paclitaxel—breast cancer	0.000604	0.000678	CcSEcCtD
Cefixime—Urticaria—Mitoxantrone—breast cancer	0.000601	0.000674	CcSEcCtD
Cefixime—Diarrhoea—Thiotepa—breast cancer	0.000599	0.000672	CcSEcCtD
Cefixime—Abdominal pain—Irinotecan—breast cancer	0.000598	0.000671	CcSEcCtD
Cefixime—Body temperature increased—Mitoxantrone—breast cancer	0.000598	0.000671	CcSEcCtD
Cefixime—Abdominal pain—Mitoxantrone—breast cancer	0.000598	0.000671	CcSEcCtD
Cefixime—Body temperature increased—Irinotecan—breast cancer	0.000598	0.000671	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000598	0.000671	CcSEcCtD
Cefixime—Pancytopenia—Epirubicin—breast cancer	0.000589	0.000661	CcSEcCtD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000587	0.0093	CbGpPWpGaD
Cefixime—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000586	0.000657	CcSEcCtD
Cefixime—Vomiting—Vinorelbine—breast cancer	0.000583	0.000654	CcSEcCtD
Cefixime—Body temperature increased—Gemcitabine—breast cancer	0.000583	0.000653	CcSEcCtD
Cefixime—Renal failure—Methotrexate—breast cancer	0.000581	0.000652	CcSEcCtD
Cefixime—Neutropenia—Epirubicin—breast cancer	0.00058	0.000651	CcSEcCtD
Cefixime—Dizziness—Thiotepa—breast cancer	0.000579	0.00065	CcSEcCtD
Cefixime—Rash—Vinorelbine—breast cancer	0.000578	0.000649	CcSEcCtD
Cefixime—Dermatitis—Vinorelbine—breast cancer	0.000578	0.000648	CcSEcCtD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000577	0.00914	CbGpPWpGaD
Cefixime—Urticaria—Fluorouracil—breast cancer	0.000576	0.000646	CcSEcCtD
Cefixime—Headache—Vinorelbine—breast cancer	0.000575	0.000645	CcSEcCtD
Cefixime—Leukopenia—Docetaxel—breast cancer	0.000574	0.000643	CcSEcCtD
Cefixime—Body temperature increased—Fluorouracil—breast cancer	0.000573	0.000642	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—breast cancer	0.000568	0.000637	CcSEcCtD
Cefixime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000565	0.00896	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000565	0.00895	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000565	0.00895	CbGpPWpGaD
Cefixime—Hypersensitivity—Mitoxantrone—breast cancer	0.000557	0.000625	CcSEcCtD
Cefixime—Hypersensitivity—Irinotecan—breast cancer	0.000557	0.000625	CcSEcCtD
Cefixime—Vomiting—Thiotepa—breast cancer	0.000557	0.000625	CcSEcCtD
Cefixime—Leukopenia—Capecitabine—breast cancer	0.000555	0.000623	CcSEcCtD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000555	0.0088	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000555	0.0088	CbGpPWpGaD
Cefixime—Convulsion—Docetaxel—breast cancer	0.000555	0.000623	CcSEcCtD
Cefixime—Rash—Thiotepa—breast cancer	0.000552	0.00062	CcSEcCtD
Cefixime—Dermatitis—Thiotepa—breast cancer	0.000552	0.000619	CcSEcCtD
Cefixime—Agranulocytosis—Methotrexate—breast cancer	0.000552	0.000619	CcSEcCtD
Cefixime—Headache—Thiotepa—breast cancer	0.000549	0.000616	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000548	0.000615	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—breast cancer	0.000545	0.000611	CcSEcCtD
Cefixime—Nausea—Vinorelbine—breast cancer	0.000545	0.000611	CcSEcCtD
Cefixime—Renal failure—Epirubicin—breast cancer	0.000544	0.00061	CcSEcCtD
Cefixime—Dyspepsia—Paclitaxel—breast cancer	0.000543	0.000609	CcSEcCtD
Cefixime—Jaundice—Epirubicin—breast cancer	0.000539	0.000605	CcSEcCtD
Cefixime—Urinary tract infection—Epirubicin—breast cancer	0.000538	0.000603	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—breast cancer	0.000537	0.000602	CcSEcCtD
Cefixime—Hypersensitivity—Fluorouracil—breast cancer	0.000534	0.000599	CcSEcCtD
Cefixime—Haemoglobin—Methotrexate—breast cancer	0.000533	0.000598	CcSEcCtD
Cefixime—Hepatitis—Methotrexate—breast cancer	0.000531	0.000595	CcSEcCtD
Cefixime—Haemorrhage—Methotrexate—breast cancer	0.000531	0.000595	CcSEcCtD
Cefixime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000525	0.00832	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000524	0.0083	CbGpPWpGaD
Cefixime—Anaphylactic shock—Docetaxel—breast cancer	0.000523	0.000587	CcSEcCtD
Cefixime—Pruritus—Gemcitabine—breast cancer	0.000521	0.000585	CcSEcCtD
Cefixime—Nausea—Thiotepa—breast cancer	0.00052	0.000584	CcSEcCtD
Cefixime—Diarrhoea—Mitoxantrone—breast cancer	0.000518	0.000581	CcSEcCtD
Cefixime—Diarrhoea—Irinotecan—breast cancer	0.000518	0.000581	CcSEcCtD
Cefixime—Agranulocytosis—Epirubicin—breast cancer	0.000516	0.000579	CcSEcCtD
Cefixime—Shock—Docetaxel—breast cancer	0.000515	0.000577	CcSEcCtD
Cefixime—Pruritus—Fluorouracil—breast cancer	0.000513	0.000575	CcSEcCtD
Cefixime—Thrombocytopenia—Docetaxel—breast cancer	0.000512	0.000574	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000507	0.000569	CcSEcCtD
Cefixime—Gastrointestinal pain—Paclitaxel—breast cancer	0.000505	0.000566	CcSEcCtD
Cefixime—Diarrhoea—Gemcitabine—breast cancer	0.000504	0.000566	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—breast cancer	0.000503	0.000564	CcSEcCtD
Cefixime—Erythema multiforme—Methotrexate—breast cancer	0.000502	0.000563	CcSEcCtD
Cefixime—Dizziness—Irinotecan—breast cancer	0.0005	0.000561	CcSEcCtD
Cefixime—Haemoglobin—Epirubicin—breast cancer	0.000499	0.00056	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—breast cancer	0.000499	0.000559	CcSEcCtD
Cefixime—Shock—Capecitabine—breast cancer	0.000498	0.000559	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—breast cancer	0.000497	0.000558	CcSEcCtD
Cefixime—Hepatitis—Epirubicin—breast cancer	0.000496	0.000557	CcSEcCtD
Cefixime—Haemorrhage—Epirubicin—breast cancer	0.000496	0.000557	CcSEcCtD
Cefixime—Diarrhoea—Fluorouracil—breast cancer	0.000496	0.000556	CcSEcCtD
Cefixime—Thrombocytopenia—Capecitabine—breast cancer	0.000496	0.000556	CcSEcCtD
Cefixime—Urticaria—Paclitaxel—breast cancer	0.00049	0.00055	CcSEcCtD
Cefixime—Body temperature increased—Paclitaxel—breast cancer	0.000488	0.000547	CcSEcCtD
Cefixime—Abdominal pain—Paclitaxel—breast cancer	0.000488	0.000547	CcSEcCtD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000486	0.0077	CbGpPWpGaD
Cefixime—Vomiting—Mitoxantrone—breast cancer	0.000481	0.000539	CcSEcCtD
Cefixime—Vomiting—Irinotecan—breast cancer	0.000481	0.000539	CcSEcCtD
Cefixime—Dizziness—Fluorouracil—breast cancer	0.000479	0.000537	CcSEcCtD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000478	0.00758	CbGpPWpGaD
Cefixime—Agranulocytosis—Doxorubicin—breast cancer	0.000478	0.000536	CcSEcCtD
Cefixime—Rash—Irinotecan—breast cancer	0.000477	0.000535	CcSEcCtD
Cefixime—Rash—Mitoxantrone—breast cancer	0.000477	0.000535	CcSEcCtD
Cefixime—Dermatitis—Mitoxantrone—breast cancer	0.000477	0.000535	CcSEcCtD
Cefixime—Dermatitis—Irinotecan—breast cancer	0.000477	0.000535	CcSEcCtD
Cefixime—Headache—Irinotecan—breast cancer	0.000474	0.000532	CcSEcCtD
Cefixime—Headache—Mitoxantrone—breast cancer	0.000474	0.000532	CcSEcCtD
Cefixime—Erythema multiforme—Epirubicin—breast cancer	0.000469	0.000527	CcSEcCtD
Cefixime—Vomiting—Gemcitabine—breast cancer	0.000469	0.000526	CcSEcCtD
Cefixime—Rash—Gemcitabine—breast cancer	0.000465	0.000521	CcSEcCtD
Cefixime—Dermatitis—Gemcitabine—breast cancer	0.000464	0.000521	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000463	0.00734	CbGpPWpGaD
Cefixime—Haemoglobin—Doxorubicin—breast cancer	0.000462	0.000518	CcSEcCtD
Cefixime—Headache—Gemcitabine—breast cancer	0.000462	0.000518	CcSEcCtD
Cefixime—Vomiting—Fluorouracil—breast cancer	0.000461	0.000517	CcSEcCtD
Cefixime—Dyspepsia—Docetaxel—breast cancer	0.00046	0.000516	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—breast cancer	0.000459	0.000515	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—breast cancer	0.000459	0.000515	CcSEcCtD
Cefixime—Rash—Fluorouracil—breast cancer	0.000457	0.000512	CcSEcCtD
Cefixime—Dermatitis—Fluorouracil—breast cancer	0.000456	0.000512	CcSEcCtD
Cefixime—Hypersensitivity—Paclitaxel—breast cancer	0.000455	0.00051	CcSEcCtD
Cefixime—Headache—Fluorouracil—breast cancer	0.000454	0.000509	CcSEcCtD
Cefixime—Nausea—Mitoxantrone—breast cancer	0.000449	0.000504	CcSEcCtD
Cefixime—Nausea—Irinotecan—breast cancer	0.000449	0.000504	CcSEcCtD
Cefixime—Dyspepsia—Capecitabine—breast cancer	0.000446	0.0005	CcSEcCtD
Cefixime—Nausea—Gemcitabine—breast cancer	0.000438	0.000491	CcSEcCtD
Cefixime—Pruritus—Paclitaxel—breast cancer	0.000437	0.00049	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—breast cancer	0.000434	0.000487	CcSEcCtD
Cefixime—Nausea—Fluorouracil—breast cancer	0.00043	0.000483	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00043	0.00682	CbGpPWpGaD
Cefixime—Gastrointestinal pain—Docetaxel—breast cancer	0.000428	0.00048	CcSEcCtD
Cefixime—Flatulence—Epirubicin—breast cancer	0.000426	0.000478	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000424	0.00672	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000424	0.00672	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000423	0.0067	CbGpPWpGaD
Cefixime—Diarrhoea—Paclitaxel—breast cancer	0.000422	0.000473	CcSEcCtD
Cefixime—Gastrointestinal pain—Capecitabine—breast cancer	0.000414	0.000464	CcSEcCtD
Cefixime—Body temperature increased—Docetaxel—breast cancer	0.000413	0.000464	CcSEcCtD
Cefixime—Abdominal pain—Docetaxel—breast cancer	0.000413	0.000464	CcSEcCtD
Cefixime—Leukopenia—Methotrexate—breast cancer	0.000413	0.000464	CcSEcCtD
Cefixime—Dizziness—Paclitaxel—breast cancer	0.000408	0.000458	CcSEcCtD
Cefixime—Urticaria—Capecitabine—breast cancer	0.000402	0.000451	CcSEcCtD
Cefixime—Abdominal pain—Capecitabine—breast cancer	0.0004	0.000449	CcSEcCtD
Cefixime—Body temperature increased—Capecitabine—breast cancer	0.0004	0.000449	CcSEcCtD
Cefixime—Convulsion—Methotrexate—breast cancer	0.0004	0.000449	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—breast cancer	0.000394	0.000442	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000393	0.00623	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000393	0.00623	CbGpPWpGaD
Cefixime—Vomiting—Paclitaxel—breast cancer	0.000392	0.00044	CcSEcCtD
Cefixime—Rash—Paclitaxel—breast cancer	0.000389	0.000436	CcSEcCtD
Cefixime—Dermatitis—Paclitaxel—breast cancer	0.000389	0.000436	CcSEcCtD
Cefixime—Leukopenia—Epirubicin—breast cancer	0.000387	0.000434	CcSEcCtD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000387	0.00613	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000387	0.00613	CbGpPWpGaD
Cefixime—Headache—Paclitaxel—breast cancer	0.000387	0.000434	CcSEcCtD
Cefixime—Hypersensitivity—Docetaxel—breast cancer	0.000385	0.000432	CcSEcCtD
Cefixime—Anaphylactic shock—Methotrexate—breast cancer	0.000377	0.000423	CcSEcCtD
Cefixime—Convulsion—Epirubicin—breast cancer	0.000374	0.00042	CcSEcCtD
Cefixime—Hypersensitivity—Capecitabine—breast cancer	0.000373	0.000418	CcSEcCtD
Cefixime—Pruritus—Docetaxel—breast cancer	0.00037	0.000415	CcSEcCtD
Cefixime—Thrombocytopenia—Methotrexate—breast cancer	0.000369	0.000414	CcSEcCtD
Cefixime—Nausea—Paclitaxel—breast cancer	0.000366	0.000411	CcSEcCtD
Cefixime—Pruritus—Capecitabine—breast cancer	0.000358	0.000402	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—breast cancer	0.000358	0.000401	CcSEcCtD
Cefixime—Diarrhoea—Docetaxel—breast cancer	0.000358	0.000401	CcSEcCtD
Cefixime—Anaphylactic shock—Epirubicin—breast cancer	0.000353	0.000396	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000351	0.00557	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000351	0.00557	CbGpPWpGaD
Cefixime—Shock—Epirubicin—breast cancer	0.000347	0.000389	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—breast cancer	0.000346	0.000389	CcSEcCtD
Cefixime—Diarrhoea—Capecitabine—breast cancer	0.000346	0.000389	CcSEcCtD
Cefixime—Dizziness—Docetaxel—breast cancer	0.000346	0.000388	CcSEcCtD
Cefixime—Thrombocytopenia—Epirubicin—breast cancer	0.000345	0.000387	CcSEcCtD
Cefixime—Dizziness—Capecitabine—breast cancer	0.000335	0.000376	CcSEcCtD
Cefixime—Vomiting—Docetaxel—breast cancer	0.000333	0.000373	CcSEcCtD
Cefixime—Dyspepsia—Methotrexate—breast cancer	0.000332	0.000372	CcSEcCtD
Cefixime—Rash—Docetaxel—breast cancer	0.00033	0.00037	CcSEcCtD
Cefixime—Dermatitis—Docetaxel—breast cancer	0.000329	0.000369	CcSEcCtD
Cefixime—Headache—Docetaxel—breast cancer	0.000328	0.000367	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—breast cancer	0.000326	0.000366	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000326	0.00517	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000326	0.00517	CbGpPWpGaD
Cefixime—Vomiting—Capecitabine—breast cancer	0.000322	0.000361	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000321	0.00509	CbGpPWpGaD
Cefixime—Shock—Doxorubicin—breast cancer	0.000321	0.00036	CcSEcCtD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00032	0.00508	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—COX11—breast cancer	0.00032	0.00508	CbGpPWpGaD
Cefixime—Thrombocytopenia—Doxorubicin—breast cancer	0.00032	0.000358	CcSEcCtD
Cefixime—Rash—Capecitabine—breast cancer	0.000319	0.000358	CcSEcCtD
Cefixime—Dermatitis—Capecitabine—breast cancer	0.000319	0.000358	CcSEcCtD
Cefixime—Headache—Capecitabine—breast cancer	0.000317	0.000356	CcSEcCtD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000315	0.00499	CbGpPWpGaD
Cefixime—Nausea—Docetaxel—breast cancer	0.000311	0.000348	CcSEcCtD
Cefixime—Dyspepsia—Epirubicin—breast cancer	0.00031	0.000348	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000309	0.0049	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000309	0.0049	CbGpPWpGaD
Cefixime—Gastrointestinal pain—Methotrexate—breast cancer	0.000308	0.000346	CcSEcCtD
Cefixime—Nausea—Capecitabine—breast cancer	0.000301	0.000337	CcSEcCtD
Cefixime—Urticaria—Methotrexate—breast cancer	0.000299	0.000336	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000298	0.00472	CbGpPWpGaD
Cefixime—Body temperature increased—Methotrexate—breast cancer	0.000298	0.000334	CcSEcCtD
Cefixime—Abdominal pain—Methotrexate—breast cancer	0.000298	0.000334	CcSEcCtD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000293	0.00465	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000292	0.00463	CbGpPWpGaD
Cefixime—Gastrointestinal pain—Epirubicin—breast cancer	0.000288	0.000324	CcSEcCtD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000288	0.00456	CbGpPWpGaD
Cefixime—Dyspepsia—Doxorubicin—breast cancer	0.000287	0.000322	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000287	0.00455	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000287	0.00455	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000282	0.00447	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000282	0.00447	CbGpPWpGaD
Cefixime—Urticaria—Epirubicin—breast cancer	0.00028	0.000314	CcSEcCtD
Cefixime—Body temperature increased—Epirubicin—breast cancer	0.000279	0.000313	CcSEcCtD
Cefixime—Abdominal pain—Epirubicin—breast cancer	0.000279	0.000313	CcSEcCtD
Cefixime—Hypersensitivity—Methotrexate—breast cancer	0.000278	0.000311	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—breast cancer	0.000267	0.000299	CcSEcCtD
Cefixime—Pruritus—Methotrexate—breast cancer	0.000267	0.000299	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000266	0.00422	CbGpPWpGaD
Cefixime—Hypersensitivity—Epirubicin—breast cancer	0.00026	0.000291	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—breast cancer	0.000259	0.000291	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—breast cancer	0.000258	0.000289	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—breast cancer	0.000258	0.000289	CcSEcCtD
Cefixime—Diarrhoea—Methotrexate—breast cancer	0.000258	0.000289	CcSEcCtD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000253	0.004	CbGpPWpGaD
Cefixime—Pruritus—Epirubicin—breast cancer	0.00025	0.00028	CcSEcCtD
Cefixime—Dizziness—Methotrexate—breast cancer	0.000249	0.00028	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000247	0.00391	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000244	0.00387	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000243	0.00386	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000243	0.00385	CbGpPWpGaD
Cefixime—Diarrhoea—Epirubicin—breast cancer	0.000241	0.000271	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—breast cancer	0.00024	0.00027	CcSEcCtD
Cefixime—Vomiting—Methotrexate—breast cancer	0.00024	0.000269	CcSEcCtD
Cefixime—Rash—Methotrexate—breast cancer	0.000238	0.000267	CcSEcCtD
Cefixime—Dermatitis—Methotrexate—breast cancer	0.000237	0.000266	CcSEcCtD
Cefixime—Headache—Methotrexate—breast cancer	0.000236	0.000265	CcSEcCtD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000234	0.00372	CbGpPWpGaD
Cefixime—Dizziness—Epirubicin—breast cancer	0.000233	0.000262	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—breast cancer	0.000231	0.000259	CcSEcCtD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000231	0.00365	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000226	0.00359	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000226	0.00359	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000226	0.00358	CbGpPWpGaD
Cefixime—Vomiting—Epirubicin—breast cancer	0.000224	0.000252	CcSEcCtD
Cefixime—Nausea—Methotrexate—breast cancer	0.000224	0.000251	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—breast cancer	0.000223	0.00025	CcSEcCtD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000223	0.00353	CbGpPWpGaD
Cefixime—Rash—Epirubicin—breast cancer	0.000222	0.000249	CcSEcCtD
Cefixime—Dermatitis—Epirubicin—breast cancer	0.000222	0.000249	CcSEcCtD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000222	0.00352	CbGpPWpGaD
Cefixime—Headache—Epirubicin—breast cancer	0.000221	0.000248	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—breast cancer	0.000216	0.000242	CcSEcCtD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.00021	0.00333	CbGpPWpGaD
Cefixime—Nausea—Epirubicin—breast cancer	0.00021	0.000235	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—breast cancer	0.000208	0.000233	CcSEcCtD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000207	0.00327	CbGpPWpGaD
Cefixime—Rash—Doxorubicin—breast cancer	0.000206	0.000231	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—breast cancer	0.000206	0.000231	CcSEcCtD
Cefixime—Headache—Doxorubicin—breast cancer	0.000204	0.000229	CcSEcCtD
Cefixime—Nausea—Doxorubicin—breast cancer	0.000194	0.000217	CcSEcCtD
Cefixime—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000192	0.00305	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000179	0.00283	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000176	0.00278	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.00016	0.00254	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000157	0.00249	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000149	0.00235	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000146	0.00232	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000146	0.00231	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000143	0.00227	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.00014	0.00222	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000135	0.00213	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.00013	0.00206	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000128	0.00203	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—TFRC—breast cancer	0.000128	0.00202	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000125	0.00198	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000124	0.00197	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000123	0.00195	CbGpPWpGaD
Cefixime—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.00012	0.00191	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000119	0.00189	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000117	0.00186	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000115	0.00182	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000113	0.0018	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000113	0.00179	CbGpPWpGaD
Cefixime—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000112	0.00177	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	0.00011	0.00175	CbGpPWpGaD
Cefixime—SLC22A5—SLC-mediated transmembrane transport—ALB—breast cancer	0.00011	0.00174	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000105	0.00167	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000103	0.00164	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000103	0.00163	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000102	0.00162	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	0.000101	0.0016	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	9.79e-05	0.00155	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.46e-05	0.0015	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	9.31e-05	0.00148	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	9.08e-05	0.00144	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	8.93e-05	0.00142	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	6.12e-05	0.000971	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	5.68e-05	0.000901	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	5.59e-05	0.000886	CbGpPWpGaD
Cefixime—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	5.54e-05	0.000878	CbGpPWpGaD
Cefixime—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	5.14e-05	0.000815	CbGpPWpGaD
Cefixime—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	5.05e-05	0.000801	CbGpPWpGaD
